ELVN News & Events

Enliven is up 9.9%, or $4.01 to $44.37.

The deal size was increased to $400M in common stock from $250M in common stock. Jefferies, Goldman Sachs, Morgan Stanley and Barclays acted as joint book running managers for the offering.

Stocks rebounded from one-month lows on Thursday as gains for chip producers offset risks of higher interest rates. AI infrastructure stocks continued to carry the momentum ahead of the SpaceX IPO tomorrow. Retail investors are said to have submitted more than $100B for the offering, due to be the largest in history. While the producer prices index pointed to accelerating price increases in May, bets on whether the Fed will raise rates this year were also influenced by President Trump calling off planned strikes against Iran and claiming that final points on a deal "have been, in both concept and great detail, approved by all parties involved."Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Oracleshares fell after the cloud giant's higher-than-expectedovershadowed strong quarterly resultsEatonannouncedits Mobility Group with Danain a Reverse Morris Trust transaction creating a combined company valued at over $10BMicrosoft'sXbox business planning significant layoffs next month,Humanaannounced anto divest its minority interest in end-of-life services provider GentivaNavanshares advanced after the AI-powered travel and expenses platform2. WALL STREET CALLS:Oppenheimerof SpaceXwith an Outperform rating and $195 price target ahead of tomorrow's initial public offeringIntelto Buy at BofA on increased foundry visibilityJefferiesGeneral Dynamicsto Buy on marine segment growthMoffettNathansonChewyafter Q1 reportAlexandria Real Estateto Underweight at Morgan Stanley3. AROUND THE WEB:Microsoftis restricting employees from using Claude Fable 5 because of Anthropic's new 30-day data retention requirements, The Verge saysA German regional court has ruled that Googleis directly liable for false claims in its AI-generated search overviews, The Decoder reportsSea'sShopee is cutting hundreds of developer jobs globally, Bloomberg saysOpenAI is considering significant price cuts for its AI services to compete with rival Anthropic, which it expects to make similar moves, WSJ reportsSoftBank'sdiscussions with potential creditors to raise $6B from a margin loan backed by its stake in OpenAI have stalled, Bloomberg says4. MOVERS:Stitch Fixgained after reporting, with EPS and revenue beating consensusVirgin Galacticincreased afterEvlivenfinished higher afterfrom the Phase 1 ENABLE trial of ELVN-001PureCycle Technologiesclosed lower after announcing aEnsign Groupfell after being targeted inthis week5. EARNINGS/GUIDANCE:Vera Bradleyreportedand backed its guidance for FY27Driven Brandsreportedand reaffirmed its outlook for FY26McGraw Hillreported Q4 results, with CEO Philip Moyeron "the strength of our strategy, the speed of our innovation and the depth of trust that we have from the education community"Lovesacprovidedand narrowed its outlook for FY27DXC Technologyits outlook for FY27 and FY29INDEXES:The Dow rose 929.97, or 1.86%, to 50,848.75, the Nasdaq gained 640.16, or 2.54%, to 25,809.66, and the S&P 500 advanced 127.31, or 1.75%, to 7,394.30.

Enliven Therapeutics announced that it has commenced an underwritten public offering of $250M of shares of its common stock and, in lieu of common stock to investors who so choose, pre-funded warrants to purchase shares of Enliven's common stock. Jefferies, Goldman Sachs & Co., Morgan Stanley and Barclays are acting as joint book-running managers for the proposed offering. Mizuho is also acting as a book-running manager and LifeSci Capital is acting as a passive book-running manager for the proposed offering.